| Literature DB >> 33272195 |
Juntao Kuang1,2, Jue Yang1, Qiuji Wang1,2, Changjiang Yu1, Ying Li1,3, Ruixin Fan4.
Abstract
BACKGROUND: Acute aortic dissection type A is a life-threatening disease required emergency surgery during acute phase. Different clinical manifestations, laboratory tests, and imaging features of patients with acute aortic dissection type A are the risk factors of preoperative mortality. This study aims to establish a simple and effective preoperative mortality risk assessment model for patients with acute aortic dissection type A.Entities:
Keywords: Preoperative mortality; Scoring model; Type A aortic dissections
Year: 2020 PMID: 33272195 PMCID: PMC7712615 DOI: 10.1186/s12872-020-01802-9
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Demographic data, history, and presenting symptoms of patients with preoperative acute aortic dissection type A
| Variable | Alive (n = 527) | Deceased (n = 146) | Total (n = 673) |
|---|---|---|---|
| DeBakey II | 74 (14.04) | 17 (11.64) | 91 (13.52) |
| Age, y | 53.70 ± 13.12 | 56.23 ± 12.39 | 54.25 ± 13.00 |
| Female | 92 (17.46) | 31 (21.23) | 123 (18.28) |
| Abrupt chest pain | 311 (59.01) | 113 (77.40) | 424 (63.00) |
| Hypertension | 310 (58.82) | 81 (55.48) | 391 (58.10) |
| Neurological disease | 37 (7.02) | 19 (13.01) | 56 (8.32) |
| Marfan syndrome | 30 (5.69) | 7 (4.79) | 37 (5.50) |
| Prior cardiovascular diseases | 50 (9.49) | 10 (6.85) | 60 (8.92) |
| Prior cardiovascular surgery | 49 (9.30) | 9 (6.16) | 58 (8.62) |
| Smoking | 158 (29.98) | 46 (31.51) | 204 (30.31) |
| Anticoagulant and antiplatelet medication within the past month | 42 (7.97) | 5 (3.42) | 47 (6.98) |
| Inotropic support | 37 (7.02) | 51 (34.93) | 88 (13.08) |
| Ventilation | 12 (2.28) | 17 (11.64) | 29 (4.31) |
Continuous variables are reported as mean and standard deviation, and categorical variables are reported as numbers (%)
Laboratory data of patients with preoperative acute aortic dissection type A
| Variable | Alive (n = 527) | Deceased (n = 146) | Total (n = 673) |
|---|---|---|---|
| Lac in ABG ≥ 3 mmol/L | 112 (21.25) | 57 (39.04) | 169 (25.11) |
| cTnT ≥ 200 pg/mL | 38 (7.21) | 21 (14.38) | 59 (8.77) |
| WBC ≥ 15 × 109/L | 144 (27.32) | 60 (41.10) | 204 (30.31) |
| RBC < 3.5 × 1012/L | 41 (7.78) | 20 (13.70) | 61 (9.06) |
| Hb < 90 g/L | 13 (2.47) | 11 (7.53) | 24 (3.57) |
| ALT ≥ 200 U/L | 23 (4.36) | 23 (15.75) | 46 (6.84) |
| AST ≥ 120 U/L | 50 (9.49) | 39 (26.71) | 89 (13.22) |
| CREA ≥ 177 µmol/L | 66 (12.52) | 35 (23.97) | 101 (15.01) |
| APTT ≥ 55 s | 30 (5.69) | 14 (9.59) | 44 (6.54) |
| D-dimmer ≥ 12,000 ng/mL | 206 (39.09) | 95 (65.07) | 301 (44.73) |
Categorical variables are reported as numbers (%)
Lac, lactic acid; ABG, arterial blood gas; cTnT, Troponin T; WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CREA, serum creatinine; APTT, activated partial thromboplastin time
Imaging features of patients with acute aortic dissection type A
| Variable | Alive (n = 527) | Deceased (n = 146) | Total (n = 673) |
|---|---|---|---|
| EF ≤ 50% | 21 (3.98) | 19 (13.01) | 87 (12.93) |
| Average ascending aorta diameter by TTE ≥ 55 mm | 54 (10.25) | 33 (22.60) | 87 (12.93) |
| Aortic insufficiency | 342 (64.90) | 110 (75.34) | 452 (67.16) |
| Severe | 68 (12.90) | 21 (14.38) | 89 (13.22) |
| Moderate | 85 (16.13) | 26 (17.81) | 111 (16.49) |
| Minor | 189 (35.86) | 63 (43.15) | 252 (37.44) |
| Moderate or massive pericardial effusion | 33 (6.26) | 22 (15.07) | 55 (8.17) |
| Electrocardiographic myocardial ischemia | 54 (10.25) | 35 (23.97) | 89 (13.22) |
| Sinotubular junction diameter by CTA ≥ 55 mm | 22 (4.17) | 16 (10.96) | 38 (5.65) |
| Ascending aorta diameter by CTA ≥ 55 mm | 84 (15.94) | 28 (19.18) | 112 (16.64) |
| FL/TL of the ascending aorta ≥ 0.75 | 117 (56.00) | 40 (27.40) | 157 (23.33) |
| FL/TL of the thoracic aorta ≥ 0.75 | 71 (13.47) | 39 (26.71) | 110 (16.34) |
| FL/TL of the abdominal aorta ≥ 0.75 | 40 (7.59) | 25 (17.12) | 65 (9.66) |
| Patent false lumen | 207 (39.28) | 93 (63.70) | 300 (44.58) |
| RCCA involvement | 76 (14.42) | 41 (28.08) | 117 (17.38) |
| IA involvement | 222 (42.13) | 90 (61.64) | 312 (46.36) |
| SMA involvement | 140 (26.57) | 68 (46.58) | 208 (30.91) |
| RA involvement | 280 (53.13) | 97 (61.64) | 342 (50.82) |
| CIA involvement | 252 (47.82) | 90 (61.64) | 342 (50.82) |
| Abdominal aortic aneurysm | 23 (4.36) | 6 (4.11) | 29 (4.31) |
Categorical variables are reported as numbers (%)
EF, ejection fraction; TTE, transthoracic echocardiography; CTA, computed tomography angiography; FL, false lumen; TL, true lumen; RCCA, right common carotid artery; IA, innominate artery; SMA, superior mesenteric artery; RA, renal artery; CIA, common iliac artery
Variables associated with mortality (n = 505)
| Variable | OR | 95% CI | |
|---|---|---|---|
| Age | 1.015 | 1.001–1.030 | 0.038 |
| Abrupt chest pain | 2.378 | 1.555–3.637 | < 0.001 |
| Inotropic support | 7.108 | 4.412–11.452 | < 0.001 |
| Ventilation | 5.654 | 2.635–12.136 | < 0.001 |
| Lac in ABG ≥ 3 mmol/L | 2.404 | 1.616–3.576 | < 0.001 |
| cTnT ≥ 200 pg/mL | 2.292 | 1.293–4.065 | 0.005 |
| WBC ≥ 15 × 109/L | 1.938 | 1.317–2.850 | 0.001 |
| RBC < 3.5 × 1012/L | 1.931 | 1.091–3.417 | 0.024 |
| Hb < 90 g/L | 3.299 | 1.445–7.536 | 0.005 |
| ALT ≥ 200 U/L | 4.188 | 2.271–7.724 | < 0.001 |
| AST ≥ 120 U/L | 3.801 | 2.368–6.103 | < 0.001 |
| CREA ≥ 177 µmol/L | 2.447 | 1.536–3.898 | < 0.001 |
| D-dimmer ≥ 12,000 ng/mL | 3.363 | 2.239–5.052 | < 0.001 |
| EF ≤ 50% | 3.748 | 1.953–7.195 | < 0.001 |
| Average ascending aorta diameter by TTE ≥ 55 mm | 2.650 | 1.635–4.294 | < 0.001 |
| Aortic insufficiency | |||
| Severe | 1.843 | 0.988–3.438 | 0.055 |
| Moderate | 1.825 | 1.017–3.277 | 0.044 |
| Minor | 1.989 | 1.230–3.216 | 0.005 |
| Moderate or massive pericardial effusion | 2.656 | 1.496–4.716 | 0.001 |
| Electrocardiographic myocardial ischemia | 2.789 | 1.737–4.478 | < 0.001 |
| CTA measured sinotubular junction diameter of ≥ 55 mm | 2.892 | 1.475–5.669 | 0.002 |
| FL/TL of the ascending aorta ≥ 0.75 | 2.269 | 1.529–3.369 | < 0.001 |
| FL/TL of the thoracic aorta ≥ 0.75 | 2.418 | 1.548–3.777 | < 0.001 |
| FL/TL of the abdominal aorta ≥ 0.75 | 2.592 | 1.511–4.447 | 0.001 |
| Patent false lumen | 2.930 | 1.983–4.327 | < 0.001 |
| RCCA involvement | 2.395 | 1.547–3.709 | < 0.001 |
| IA involvement | 2.369 | 1.612–3.481 | < 0.001 |
| SMA involvement | 2.528 | 1.724–3.708 | < 0.001 |
| RA involvement | 1.890 | 1.272–2.807 | 0.002 |
| CIA involvement | 1.877 | 1.278–2.756 | 0.001 |
CI, confidence interval; OR, odds ratio; Lac, lactic acid; ABG, arterial blood gas; cTnT, Troponin T; WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CREA, serum creatinine; EF, ejection fraction; TTE, transthoracic echocardiography; CTA, computed tomography angiography; FL, false lumen; TL, true lumen; RCCA, right common carotid artery; IA, innominate artery; SMA, superior mesenteric artery; RA, renal artery; CIA, common iliac artery
Preoperative prediction model
| Variable | OR | 95% CI | Coefficient & score assigned | |
|---|---|---|---|---|
| Age | 1.008 | 0.985–1.030 | 0.008 | 0.510 |
| Abrupt chest pain | 3.534 | 1.872–6.672 | 1.262 | < 0.001 |
| Lac in ABG ≥ 3 mmol/L | 3.636 | 2.047–6.461 | 1.291 | < 0.001 |
| Inotropic support | 8.615 | 4.361–17.019 | 2.154 | < 0.001 |
| Electrocardiographic myocardial ischemia | 3.300 | 1.621–6.718 | 1.194 | 0.001 |
| IA involvement | 1.625 | 0.905–2.918 | 0.486 | 0.104 |
| RCCA involvement | 3.487 | 1.706–7.127 | 1.249 | 0.001 |
| SMA involvement | 2.651 | 1.527–4.602 | 0.975 | 0.001 |
| FL/TL of the ascending aorta of ≥ 0.75 | 2.221 | 1.238–3.984 | 0.798 | 0.007 |
CI, confidence interval; OR, odds ratio; ABG, arterial blood gas; FL, false lumen; TL, true lumen; RCCA, right common carotid artery; IA, innominate artery; SMA, superior mesenteric artery
Fig. 1Receiver operating characteristic curve (blue line) for the developmental dataset (n = 505)
Fig. 2Receiver operating characteristic curve (blue line) for the validation dataset (n = 168)